PlainRecalls
FDA Drug Critical Class I Terminated

Ceftriaxone for Injection USP, 1 g, packaged in a) one Single Use Vial (NDC 68180-633-01) and b) 10 Single Use Vials per box (NDC 68180-633-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.

Reported: January 16, 2019 Initiated: December 20, 2018 #D-0357-2019

Product Description

Ceftriaxone for Injection USP, 1 g, packaged in a) one Single Use Vial (NDC 68180-633-01) and b) 10 Single Use Vials per box (NDC 68180-633-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.

Reason for Recall

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Details

Units Affected
a) 35,000 vials; b) 112,641 boxes
Distribution
Nationwide in the USA and Puerto Rico.
Location
Baltimore, MD

Frequently Asked Questions

What product was recalled?
Ceftriaxone for Injection USP, 1 g, packaged in a) one Single Use Vial (NDC 68180-633-01) and b) 10 Single Use Vials per box (NDC 68180-633-10); Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., 111 South Calvert Street, Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Mandideep 462 046 INDIA.. Recalled by Lupin Pharmaceuticals Inc.. Units affected: a) 35,000 vials; b) 112,641 boxes.
Why was this product recalled?
Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.
Which agency issued this recall?
This recall was issued by the FDA Drug on January 16, 2019. Severity: Critical. Recall number: D-0357-2019.